Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q2 2016 · 10-Q
Revenue$3.54M$3.54M−37.6% vs Q2 2015 Net Income-$2.45M-$2.45MN/M vs Q2 2015 EPS Diluted-$0.06-$0.06N/M vs Q2 2015 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flowderived-$748,323N/M Free Cash Flowderived-$775,288N/M Margins · derivedGross margin13.6%+14.6 pt vs Q2 2015
Operating margin-62.7%+4.3 pt vs Q2 2015
Net margin-69.3%−89.1 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 11, 2016 · 42 d after period end